Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer
PDF

Article - Comment

Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer

Bull Urooncol 2007;6(2):36-38
,
PDF
Permissions